CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing prevalence of chronic diseases
4.1.2. Increase in government investments for cell-based research
4.1.3. Growing initiatives by companies for research and development of cell-based therapies
4.1.4. Increasing number of GMP-certified cell therapy production facilities
4.1.5. Growing demand for pharmaceuticals
4.2. Market Restraints & Challenges
4.2.1. High cost involved in operations
4.2.2. Ethical concerns regarding research on cell biology
4.3. Market Opportunities
4.3.1. Technological advancements in 3D cell expansion
4.3.2. Emerging countries with high growth opportunities
CHAPTER 5. GLOBAL CELL EXPANSION MARKET – BY PRODUCT
5.1. Consumables
5.1.1. Reagents, Media, and Serum
5.1.2. Disposables
5.1.1.1 Tissue Culture Flasks
5.1.1.2 Bioreactor Accessories
5.1.1.3 Other Disposables
5.2. Instruments
5.2.1. Cell Expansion Supporting Equipment
5.2.1.1 Flow Cytometers
5.2.1.2 Centrifuges
5.2.1.3 Cell Counters
5.2.1.4 Other Supporting Equipment
5.2.2. Bioreactors
5.2.2.1. Microcarrier Bioreactors
5.2.2.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors
5.2.2.1.2 Suspension-Based Anchorage Independent Bioreactors
5.2.2.2 Perfusion/Hollow Fiber Bioreactors
5.2.3. Automated Cell Expansion Systems
CHAPTER 6. GLOBAL CELL EXPANSION MARKET – BY CELL TYPE
6.1. Human Cells
6.1.1. Stem Cells
6.1.1.1 Adult Stem Cells
6.1.1.2 Induced Pluripotent Stem Cells
6.1.1.3 Embryonic Stem Cells
6.1.2. Differentiated Cells
6.2. Animal Cells
CHAPTER 7. GLOBAL CELL EXPANSION MARKET – BY APPLICATION
7.1. Regenerative Medicine and Stem Cell Research
7.2. Cancer and Cell-Based Research
7.3. Others
CHAPTER 8. GLOBAL CELL EXPANSION MARKET – BY END USER
8.1. Research Institutes
8.2. Biopharmaceutical and Biotechnology Companies
8.3. Cell Banks
8.4. Others
CHAPTER 9. GLOBAL CELL EXPANSION MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL CELL EXPANSION MARKET - COMPANY PROFILES
10.1. Lonza Group Ltd.
10.2. Becton, Dickinson and Company
10.3. Corning, Inc.
10.4. Merck KGAA
10.5. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
10.6. Miltenyi Biotec
10.7. Stemcell Technologies
10.8. Terumo BCT, Inc.
10.9. Thermo Fisher Scientific, Inc.
10.10. GE Healthcare
10.11. Stem cell Technologies, Inc.
10.12. BD Biosciences
10.12. Danaher Corporation
CHAPTER 11. GLOBAL CELL EXPANSION MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
